Blogs

GENEU Chief Scientific Officer Professor Christofer Toumazou Honoured With IEEE Field Medal In Biomedical Engineering

London, UK, 27th May 2015 – GENEU, creator of the world’s first in-store DNA test for personalised skincare, today announces that GENEU’s Chief Scientific Officer and inventor of the core technology behind its high street revolution, Professor Chris Toumazou, has been awarded the prestigious IEEE Field Medal in Biomedical Engineering. The Institute of Electrical and Electronics Engineers – the world's largest technical professional society – has honoured Professor Toumazou with the IEEE Field Medal in Biomedical Engineering in recognition of his “outstanding contributions to biomedical circuit technology”. The award was president by IEEE President and CEO, Howard E. Michel, during the ISCAS international symposium in Lisbon.

PCG announces new representation agreement with Japanese medical publisher Meteo

Boston, US, 30th April 2015 – Sales, marketing and research consultancy Publishers Communication Group (PCG), a division of Publishing Technology plc, has signed a new sales representation deal with leading Japanese medical publisher, Meteo, to help expand the reach of its Medical Online-E information service into North and South America.

Hosting around 800 medical journals, over 1.3 million articles as well as references and abstracts, Medical Online-E is designed to deliver the very best Japanese medical content and expertise to English speaking audiences around the world. The site aggregates content in English from a diverse range of medical fields, including: general medicine, clinical surgery, dentistry, medical technology, nursing, nutrition, pharmaceutical sciences, public health, and many more.

ELC Group signs 1.5 million Euro regulatory affairs contract with Chinese pharma giant

Cambridge, UK, 21st April 2015 – ELC Group, one of the fastest-growing providers of regulatory affairs services, today announces that it has been awarded a 1.5 million Euro contract by one of China’s biggest pharmaceutical companies.

The contract award is a major endorsement of ELC Group’s new Concept to Commercialisation solution approach, which delivers a highly integrated portfolio of regulatory affairs consultancy services to customers, from the development stage through to the implementation of clinical trials, completion of product registration, and successful marketing of the product.

The major project, which will see two products taken through ELC Group’s end-to-end Concept to Commercialisation service, is expected to be complete by the end of 2016. The customer, one of the top 25 Chinese pharmaceutical companies, is an active pharmaceutical ingredient company that is moving towards the finished formulation business.

Advanced research instrumentation specialists Oxford Optronix to showcase solutions at The Genes & Cancer Meeting in Cambridge,

Abingdon, UK, 17th March 2015 – Oxford Optronix, the leading provider of advanced research instrumentation for the clinical medicine and life science industries, today announces that it will be showcasing its full range of cancer research solutions at The Genes & Cancer Annual Meeting at Robinson College, Cambridge, UK, from 13 - 15 April 2015.

Oxford Optronix will be exhibiting throughout the two-day event, which is now in its 31st year and is the longest-running cancer research meeting in the UK. The Oxford Optronix team will demonstrate its full range of advanced instrumentation products, including the next-generation OxyLite™ dissolved oxygen (pO2) and temperature monitors, the GelCount™ colony counter platform for cancer biologists and its recently launched HypoxyLab™ hypoxia workstation.

Fast-growing regulatory affairs service provider ELC Group expands corporate presence in Czech Republic

Cambridge, UK, 24th February 2015 – ELC Group, one of the fastest-growing providers of regulatory affairs services, today announces that it is expanding its office presence in Prague in the Czech Republic due to accelerating company growth. From May, ELC Group will be occupying nearly 2000 square metres of offices at Danube House, located in the prime River City Prague business district.

The move is being fuelled by ELC Group’s rapidly expanding customer base, which includes recent major contract wins in China and the US. The increased office space will accommodate ELC Group’s growing team of project management staff and subject matter experts, with staff numbers based in the Czech capital set to almost double within the next three months.

Mobile fleet operator sets its sights on European expansion

Gloucester, UK, 3rd February 2015 – The operator of the world’s largest fleet of mobile operating theatres is targeting expansion in Europe in the wake of the ECB’s plan to inject €1.1 trillion into the Eurozone.

Vanguard Healthcare has appointed Mary Smallbone to the newly-created post of Managing Director Europe and is rolling out its UK-developed healthcare technology into mainland Europe.

Smallbone, a qualified theatre nurse, ran regional sales teams for Smith & Nephew before joining Vanguard in 2003 as Director of Sales and Marketing. She added Operations to her portfolio in 2007 and has already overseen contracts for the company in Italy, Belgium, the Netherlands and Sweden.

Vanguard’s main business is providing mobile operating theatres and mobile wards, usually with experienced theatre staff, to NHS and private hospitals in the UK. More than 200,000 patients have been treated on its fleet of 37 mobiles which include three mobile endoscopy units.

Pages

Subscribe to RSS - blogs